Bryce Wallis Admitted to Master of Science in Clinical Investigation Program
Congratulations to Molecular Pharmaceutics PhD student Bryce Wallis (Lim Lab) who was admitted to the Med into Grad Program (U2M2G) in fall 2022. This program provides the didactic and mentoring support to train this new breed of PhD scientists. U2M2G activities and mentoring are integrated with department-based requirements in order to provide comprehensive medical science education that will assist pre-doctoral students at each step of their graduate work, from preliminary examinations and thesis research, to developing long-term lines of investigation with an eye to translation and relevance to human disease.
In January 2023 Bryce was awarded a scholarship from the Master of Science in Clinical Investigation Program to help cover her tuition. Congratulations Bryce on this exciting program!
